ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of its Phantom® Metatarsal Shortening System which features a first in-kind intramedullary device for ...
Please provide your email address to receive an email when new articles are posted on . Nextremity Solutions recently announced receipt of both FDA clearance and CE Mark certification of its MSP ...
It's a congenital disorder attributed to the abnormal shortening of the metatarsal bone. Human beings are endowed with five elongated bones, to which the toes are attached. The metatarsal bones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback